Category: clinical trials
-
The NIH just announced that a highly novel Phase 3 clinical trial of a CoV-2 RNA vaccine was launched today.
-
As reported two months ago in these pages, the vaccine that seems to have the early lead is being developed at England’s Oxford University in partnership with the pharma company AstraZeneca. On Monday, they reported encouraging results from their combination phase 1/2 study in the journal The Lancet.
-
Today, several news sources are running with headlines that the WHO has stopped testing hydroxychloroquine. That is misleading.
